关注
Esteban Martinez
Esteban Martinez
Infectious Diseases Unit, Hospital Clínic-IDIBAPS, University of Barcelona
在 clinic.cat 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study
E Martinez, A Mocroft, MA García-Viejo, JB Pérez-Cuevas, JL Blanco, ...
The Lancet 357 (9256), 592-598, 2001
5642001
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients
M Laguno, J Murillas, JL Blanco, E Martínez, R Miquel, ...
Aids 18 (13), 27-36, 2004
5112004
COVID-19 in patients with HIV: clinical case series
JL Blanco, J Ambrosioni, F Garcia, E Martínez, A Soriano, J Mallolas, ...
The lancet. HIV 7 (5), e314, 2020
5082020
Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy
E Martínez, JL Blanco, JA Arnaiz, JB Pérez-Cuevas, A Mocroft, A Cruceta, ...
Aids 15 (10), 1261-1268, 2001
4702001
Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine
E Martínez, I Conget, L Lozano, R Casamitjana, JM Gatell
Aids 13 (7), 805-810, 1999
4051999
Incidence and severity of COVID-19 in HIV-positive persons receiving antiretroviral therapy: a cohort study
J Del Amo, R Polo, S Moreno, A Díaz, E Martínez, JR Arribas, I Jarrín, ...
Annals of internal medicine 173 (7), 536-541, 2020
3892020
Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection
E Martínez, JA Arnaiz, D Podzamczer, D Dalmau, E Ribera, P Domingo, ...
New England Journal of Medicine 349 (11), 1036-1046, 2003
3882003
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
J Berenguer, P Ryan, J Rodriguez-Bano, I Jarrín, J Carratala, J Pachón, ...
Clinical Microbiology and Infection 26 (11), 1525-1536, 2020
3602020
European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV*
JD Lundgren, M Battegay, G Behrens, S De Wit, G Guaraldi, C Katlama, ...
HIV medicine 9 (2), 72-81, 2008
2832008
Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count
F García, E de Lazzari, M Plana, P Castro, G Mestre, M Nomdedeu, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 36 (2), 702-713, 2004
2722004
Continuous antiretroviral therapy decreases bone mineral density
B Grund, G Peng, CL Gibert, JF Hoy, RL Isaksson, JC Shlay, E Martinez, ...
Aids 23 (12), 1519-1529, 2009
2682009
Severe nucleoside-associated lactic acidosis in human immunodeficiency virus–infected patients: report of 12 cases and review of the literature
V Falcó, D Rodríguez, E Ribera, E Martínez, JM Miró, P Domingo, ...
Clinical infectious diseases 34 (6), 838-846, 2002
2552002
Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy
A Suy, E Martínez, O Coll, M Lonca, M Palacio, E de Lazzari, M Larrousse, ...
Aids 20 (1), 59-66, 2006
2442006
Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults
MA Marcos, MTJ de Anta, JP de la Bellacasa, J González, E Martinez, ...
European Respiratory Journal 21 (2), 209-214, 2003
2412003
Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study
E Martinez, M Larrousse, JM Llibre, F Gutierrez, M Saumoy, A Antela, ...
Aids 24 (11), 1697-1707, 2010
2402010
The role of viruses in the aetiology of community-acquired pneumonia in adults
MA Marcos, M Camps, T Pumarola, JA Martinez, E Martinez, J Mensa, ...
Antiviral therapy 11 (3), 351-359, 2006
2172006
High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors
E Martínez, J Gatell, Y Morán, E Aznar, E Buira, A Guelar, J Mallolas, ...
Clinical infectious diseases 27 (6), 1510-1513, 1998
1931998
Impact of switching from human immunodeficiency virus type 1 protease inhibitors to efavirenz in successfully treated adults with lipodystrophy
E Martínez, MA García-Viejo, JL Blanco, L Bianchi, E Buira, I Conget, ...
Clinical infectious diseases 31 (5), 1266-1273, 2000
1912000
Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretrovirals
O Miró, S López, E Martínez, E Pedrol, A Milinkovic, E Deig, G Garrabou, ...
Clinical infectious diseases 39 (5), 710-716, 2004
1792004
A Randomized Trial of the Discontinuation of Primary and Secondary Prophylaxis against Pneumocystis carinii Pneumonia after Highly Active Antiretroviral …
JCLB de Quiros, JM Miro, JM Peña, D Podzamczer, JC Alberdi, ...
New England Journal of Medicine 344 (3), 159-167, 2001
176*2001
系统目前无法执行此操作,请稍后再试。
文章 1–20